Pelican Therapeutics Raises $15.2M Via Research Grant

Austin-based Pelican Therapeutics, which is developing treatments for cancer, said today that it has won a $15.2M New Company Product Development Award, from the Cancer Prevention and Research Institute of Texas (CPRIT). According to the company, the funding will go towards developing a monoclonal antibody, PTX-25, and setting up a corporate headquarters and laboratory facilities in Austin. Pelican Therapeutics is led by Josiah Hornblower.